E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell line.
about
Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinomaDifferential regulation of MMPs by E2F1, Sp1 and NF-kappa B controls the small cell lung cancer invasive phenotypeTALE homeodomain proteins regulate site-specific terminal differentiation, LCE genes and epidermal barrier.Phosphorylation by c-Jun NH2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosisPMA stimulates MUC5B gene expression through an Sp1-based mechanism in airway epithelial cells.Apoptotic effect of Polygonum Cuspidatum in oral cancer cells through the regulation of specificity protein 1.
P2860
E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell line.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
E2F suppression and Sp1 overex ...... mous cell carcinoma cell line.
@en
type
label
E2F suppression and Sp1 overex ...... mous cell carcinoma cell line.
@en
prefLabel
E2F suppression and Sp1 overex ...... mous cell carcinoma cell line.
@en
P2093
P2860
P356
P1433
P1476
E2F suppression and Sp1 overex ...... mous cell carcinoma cell line.
@en
P2093
Alison L Dahler
Chung Fai Wong
Claudia Popa
Liam M Barnes
Louise Smith
Magdalena M Serewko-Auret
Nicholas A Saunders
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208372
P407
P577
2005-05-01T00:00:00Z
P6179
1014531362